• English
    • Ελληνικά
  • English 
    • English
    • Ελληνικά
  • Login
Browsing by Subject 
  •   Home
  • Browsing by Subject
  •   Home
  • Browsing by Subject
JavaScript is disabled for your browser. Some features of this site may not work without it.

Browsing by Subject "Oncology"

  • 0-9
  • Α
  • Β
  • Γ
  • Δ
  • Ε
  • Ζ
  • Η
  • Θ
  • Ι
  • Κ
  • Λ
  • Μ
  • Ν
  • Ξ
  • Ο
  • Π
  • Ρ
  • Σ
  • Τ
  • Υ
  • Φ
  • Χ
  • Ψ
  • Ω
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Sort by:

Order:

Results:

Now showing items 1-20 of 37

  • title
  • submit date
  • accessioned date
  • ascending
  • descending
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
    • Article  

      Anxiety, depression and defense mechanisms associated with treatment decisional preferences and quality of life in non-metastatic breast cancer: A 1-year prospective study 

      Hyphantis, T.; Almyroudi, A.; Paika, V.; Degner, L. F.; Carvalho, A. F.; Pavlidis, Nicholas (2013)
      Objective: Treatment decisional preferences impact breast cancer patients' health-related quality of life (HRQoL) and may relate to psychological variables, although many aspects of this relationship remain unknown. This ...

    • Article  

      Brain metastasis of unknown primary: A diagnostic and therapeutic dilemma 

      Polyzoidis, K. S.; Miliaras, G.; Pavlidis, Nicholas (2005)
      The diagnosis of a brain metastasis is usually made during the routine follow up examinations of patients with known cancer, who are under the care of oncology departments. The involvement of the neurosurgeon depends on ...

    • Article  

      Cationic nanoparticles have superior transvascular flux into solid tumors: Insights from a mathematical model 

      Stylianopoulos, T.; Soteriou, K.; Fukumura, D.; Jain, R. K. (2013)
      Despite their great promise, only a few nanoparticle formulations have been approved for clinical use in oncology. The failure of nano-scale drugs to enhance cancer therapy is in large part due to inefficient delivery. To ...

    • Article  

      Computer-aided detection of breast cancer nuclei 

      Schnorrenberg, F.; Pattichis, Constantinos S.; Kyriacou, Kyriacos C.; Schizas, Christos N. (1997)
      A computer-aided detection system for tissue cell nuclei in histological sections is introduced and validated as part of the Biopsy Analysis Support System (BASS). Cell nuclei are selectively stained with monoclonal ...

    • Article  

      Decision-making preferences and information needs among Greek breast cancer patients 

      Almyroudi, A.; Degner, L. F.; Paika, V.; Pavlidis, Nicholas; Hyphantis, T. (2011)
      Objectives: We aimed at assessing Greek breast cancer patients' preferences for participation in treatment decision making and their information needs. Methods: In a cross-sectional study, 329 breast cancer patients were ...

    • Article  

      Design considerations for nanotherapeutics in oncology 

      Stylianopoulos, T.; Jain, R. K. (2015)
      Nanotherapeutics have improved the quality of life of cancer patients, primarily by reducing the adverse effects of chemotherapeutic agents, but improvements in overall survival are modest. This is in large part due to the ...

    • Conference Object  

      Design rules for cancer nanomedicines 

      Stylianopoulos, T.; Soteriou, K.; Fukumura, D.; Jain, R. K. (Affiliation: Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, CyprusAffiliation: Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United StatesCorrespondence Address: Stylianopoulos, T.Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus, 2012)
      The use of nanotechnology has offered new hope for cancer detection, prevention and treatment. Nanoparticle formulations are advantageous over conventional chemotherapy because they can incorporate multiple diagnostic and ...

    • Article  

      Diffuse large cell lymphomas: Identification of prognostic factors and validation of the international non-Hodgkin's Lymphoma Prognostic Index 

      Nikolaides, C.; Fountzilas, George; Zoumbos, N.; Skarlos, Dimosthenis V.; Kosmidis, Paraskevas A.; Pectasides, Dimitrios; Karabelis, A.; Giannakakis, T.; Symeonidis, A.; Papadopoulos, A.; Antoniou, F.; Pavlidis, Nicholas (1998)
      Several clinical prognostic factors have been identified that predict treatment outcome in patients with diffuse large cell lymphomas. An International Non-Hodgkin's Lymphoma Prognostic Index (IPI) has been recently ...

    • Article  

      Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group 

      Skarlos, Dimosthenis V.; Dimopoulos, M. A.; Kosmidis, Paraskevas A.; Papakostas, P.; Pavlidis, Nicholas; Bacoyiannis, Charalambos; Kiamouris, Ch; Klouvas, G. D.; Gogas, H.; Fountzilas, George; Samantas, E. (2003)
      There is some evidence that taxanes and gemcitabine are effective antitumor agents against small-cell lung cancer (SCLC). A total of 20 chemotherapy-naive patients with extensive disease (ED) SCLC, were treated as a part ...

    • Article  

      ESMO clinical practice guidelines: Development, implementation and dissemination 

      Pavlidis, Nicholas; Hansen, H.; Stahel, R. A. (2010)

    • Article  

      ESMO clinical recommendations: a practical guide for medical oncologists. 

      Pavlidis, Nicholas; Hansen, H.; Stahel, R. A. (2007)

    • Article  

      ESMO clinical recommendations: Using the easier and faster approach to oncology guidelines 

      Pavlidis, Nicholas; Hansen, H.; Stahel, R. A. (2009)

    • Article  

      ESMO consensus conferences: Another source of ESMO clinical practice guidelines 

      Pavlidis, Nicholas; Stahel, R. A.; Pentheroudakis, George; Cervantes, A. (2012)

    • Article  

      The ESMO guideline strategy: An identity statement and reflections on improvement 

      Pentheroudakis, George; Cardoso, Fatima; Arnold, D.; Sessa, Cristiana; Peters, S.; Horwich, A.; Pavlidis, Nicholas; Stahel, R. A.; Cervantes, A. (2015)
      Guidelines should provide recommendations on the optimal management of a patient in specific clinical circumstances based on the scientific evidence. ESMO, as Europe's leading society in medical oncology produces a range ...

    • Article  

      ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016 

      Dittrich, C.; Kosty, M.; Jezdic, S.; Pyle, D.; Berardi, Rossana; Bergh, Jonas; Saghir, Nagi El; Lotz, J. P.; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta (2016)

    • Article  

      Evidence-based medicine: Development and implementation of guidelines in oncology 

      Pavlidis, Nicholas (2009)

    • Article  

      Forty years experience of treating cancer of unknown primary 

      Pavlidis, Nicholas (2007)
      Cancer of unknown primary site (CUP) is not a rare tumour. It accounts as the seventh to eighth most frequently diagnosed cancer in a general medical oncology service. Since CUP is not a homogeneous disease and it consists ...

    • Article  

      Fourteen years of evolution of ESMO guidelines: From the minimum recommendations to the Consensus Conference-derived guidelines 

      Pavlidis, Nicholas; Stahel, R. A.; Hansen, H.; Cervantes, A. (2011)

    • Article  

      Global curriculum edition 2016: European society for medical oncology/American society of clinical oncology recommendations for training in medical oncology 

      Dittrich, C.; Kosty, M. P.; Jezdic, S.; Pyle, D.; Berardi, Rossana; Bergh, Jonas; Nagi, S. E.-S.; Lotz, J. P.; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta (2017)

    • Article  

      Heterogeneity in cancer guidelines: Should we eradicate or tolerate? 

      Pentheroudakis, George; Stahel, R. A.; Hansen, H.; Pavlidis, Nicholas (2008)
      Background: Heterogeneity in aspects of development, structure and context of oncology guidelines was not evaluated. We analysed and critically examined its implications. Materials and methods: Nine cancer clinical practice ...

      Browse

      EverywhereCommunities & CollectionsBy Submission DateAuthorsTitlesSubjectsBy TypeBy DepartmentBy Faculty

      My Account

      Login
      Πνευματικά δικαιώματα ©  Βιβλιοθήκη Πανεπιστημίου Κύπρου
      Contact Us | Send Feedback
      Οδηγίες κατάθεσης διδακτορικής διατριβής
      Open Access
      ORCiD